MoneyWorks4Me

Shree Ganesh Remed. - Quaterly Results

19 May 2025 Evaluate
A decrease of about -34.55% in the sales to Rs. 244.32 millions was observed for the quarter ended March 2025. The sales stood at Rs. 373.32 millions during the similar quarter previous year.The Net Profit of the company slipped to Rs. 65.97 millions from Rs. 125.93 millions, a decline of -47.61% on QoQ basis.The company reported a degrowth in operating Profit to 121.63 millions from 182.55 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 244.32 373.32 -34.55 1085.96 1258.95 -13.74 1085.96 1258.95 -13.74
Other Income 22.87 13.24 72.73 37.30 30.71 21.46 37.30 30.71 21.46
PBIDT 121.63 182.55 -33.37 429.42 448.77 -4.31 429.42 448.77 -4.31
Interest 9.58 1.46 556.16 20.77 5.98 247.32 20.77 5.98 247.32
PBDT 112.05 181.09 -38.12 408.65 442.79 -7.71 408.65 442.79 -7.71
Depreciation 24.24 18.57 30.53 95.67 61.10 56.58 95.67 61.10 56.58
PBT 87.81 162.52 -45.97 312.98 381.69 -18.00 312.98 381.69 -18.00
TAX 21.84 36.59 -40.31 81.99 100.52 -18.43 81.99 100.52 -18.43
Deferred Tax -0.81 -0.15 440.00 -0.45 6.74 -106.68 -0.45 6.74 -106.68
PAT 65.97 125.93 -47.61 230.99 281.17 -17.85 230.99 281.17 -17.85
Equity 128.38 125.83 2.03 128.38 125.83 2.03 128.38 125.83 2.03
PBIDTM(%) 49.78 48.90 1.81 39.54 35.65 10.93 39.54 35.65 10.93
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..